Huntsworth plc announced the acquisition of New York-based AboveNation Media LLC, adding to its collection of leading health, wellness and lifestyle marketing companies under Evoke Group.
The world’s largest diabetes drugmaker, Novo Nordisk, presented the first successful data from a large final-stage study of a pill the company hopes will transform the diabetes market.
A vast research study that sought to settle a long-standing debate about whether or not anti-depressant drugs really work has found they are indeed effective in relieving acute depression in adults.
An advisory committee of the U.S. CDC recommended the use of AstraZeneca’s FluMist Quadrivalent vaccine in the upcoming flu season, reversing its earlier position.
A new chief executive officer and a fresh infusion of $50 million in Series C funding has given ORIC Pharmaceuticals Inc. a shot in the arm as the South San Francisco-based company continues to push development of its lead asset for treatment-resistant cancers.
The U.S. FDA granted San Diego-based Evofem Biosciences Fast Track designation for Amphora vaginal gel to prevent urogenital chlamydia infection in women.
AbbVie and Neurocrine Biosciences’ Phase III ELARIS UF-1 clinical trial of elagolix for uterine fibroids hit its primary endpoint.
Fast Company recently published The World’s 50 Most Innovative Companies 2018, topping off its edition of the top 350 most innovative companies. Here is a look at the life science companies that made the list.
Merck & Co. is driving forward in its quest to develop a premier immuno-oncology pipeline with the acquisition of Australia-based Viralytics Ltd. and its oncolytic immunotherapy treatments.
Inception Digital – the premiere broadcast production and delivery company – announced the introduction of Pando, a groundbreaking meeting platform that enables face-to-face collaboration delivered remotely.